MVAC regimen
WikiDoc Resources for MVAC regimen |
Articles |
---|
Most recent articles on MVAC regimen Most cited articles on MVAC regimen |
Media |
Powerpoint slides on MVAC regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on MVAC regimen at Clinical Trials.gov Clinical Trials on MVAC regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on MVAC regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on MVAC regimen Discussion groups on MVAC regimen Patient Handouts on MVAC regimen Directions to Hospitals Treating MVAC regimen Risk calculators and risk factors for MVAC regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for MVAC regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: Methotrexate-Vinblastine-Adriamycin-Cisplatin Regimen; MVAC Regimen
Overview
MVAC regimen refers to a regimen consisting of methotrexate, vinblastine, doxorubicin (Adriamycin) and cisplatin used for the treatment of advanced-stage bladder cancer.[1][2]
Regimen
MMethotrexate
VVinblastine ADoxorubicin (Adriamycin)
CCisplatin
Indications
- Advanced-stage bladder cancer.[1][3]
References
- ↑ 1.0 1.1 Killock D (2014). "Bladder cancer: Accelerating MVAC". Nat Rev Urol. 11 (6): 307. doi:10.1038/nrurol.2014.128. PMID 24861327.
- ↑ "NCI Thesaurus".
- ↑ "NCI Thesaurus".